| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/2006 | DE19925211B4 Kit zur Herstellung einer Formulierung von Paclitaxel Kit for preparing a formulation of paclitaxel |
| 01/12/2006 | DE102004030044A1 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels Triterpenhaltiger oleogel-forming agent, triterpenhaltiges oleogel and method for producing a triterpenhaltigen oleogel |
| 01/12/2006 | CA2628005A1 Oral antimicrobial pharmaceutical compositions |
| 01/12/2006 | CA2573042A1 Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction |
| 01/12/2006 | CA2572167A1 Quinolone-containing medicinal composition |
| 01/12/2006 | CA2571725A1 Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 01/12/2006 | CA2571292A1 Polymer-factor ix moiety conjugates |
| 01/12/2006 | CA2569679A1 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | CA2568262A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 01/12/2006 | CA2559503A1 Lubricant for the ocular surface |
| 01/12/2006 | CA2558767A1 Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates anddrugs obtained therefrom |
| 01/11/2006 | EP1614696A1 N-methyl-amide derivatives of Carboxymethylcellulose, alginic acid N-methyl-amide or carboxymethyl starch |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614431A2 Compositions for treatment of disorders of the oesophagus |
| 01/11/2006 | EP1614416A2 Method for treating amyloidosis |
| 01/11/2006 | EP1613749A2 Ligand-coupled initiator polymers and methods of use |
| 01/11/2006 | EP1613644A1 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof |
| 01/11/2006 | EP1613610A1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 01/11/2006 | EP1613554A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/11/2006 | EP1613423A1 Encapsulation system |
| 01/11/2006 | EP1613369A2 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 01/11/2006 | EP1613357A1 Gonadotropin releasing hormone analogue conjugates with steroid hormones |
| 01/11/2006 | EP1613356A1 A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxy acid |
| 01/11/2006 | EP1613354A2 Improved penetration of active substances into cells and organs |
| 01/11/2006 | EP1613352A2 Micro-cluster compositions |
| 01/11/2006 | EP1613344A2 Anti-tumor vasculature effects of human serum albumin derivatives |
| 01/11/2006 | EP1613343A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 01/11/2006 | EP1613334A2 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 01/11/2006 | EP1613314A1 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases |
| 01/11/2006 | EP1613302A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
| 01/11/2006 | EP1613300A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/11/2006 | EP1613288A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 01/11/2006 | EP1613285A2 Lipid particles having asymmetric lipid coating and method of preparing same |
| 01/11/2006 | EP1613283A1 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
| 01/11/2006 | EP1613279A1 Oral administration form for veterinary use |
| 01/11/2006 | EP1613276A1 Low viscosity liquid dosage forms |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613270A2 Film forming polymers, methods of use, and devices and applications thereof |
| 01/11/2006 | EP1613261A2 Intracellular formation of peptide conjugates |
| 01/11/2006 | EP1613254A2 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 01/11/2006 | EP1613179A2 Methods and systems for determining and controlling glycemic responses |
| 01/11/2006 | EP1556084A4 Methods of regulating body weight |
| 01/11/2006 | EP1469743A4 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1385489B1 Coated granules based on angiotensin-converting enzyme inhibitor |
| 01/11/2006 | EP1294402B1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/11/2006 | EP1183302B1 Controlled release polyacrylic acid granules and a process for preparing the same |
| 01/11/2006 | EP1156830B1 Use of an oil-in-water emulsion for the manufacture of a medicament |
| 01/11/2006 | EP1144452B1 Modified antibodies and antibody fragments with increased duration of activity |
| 01/11/2006 | EP1142573B1 Pharmaceutical compositions comprising faropenem sodium and a diamineacetate compound for improving gastrointestinal absorption |
| 01/11/2006 | EP1119630B1 Nucleic acid constructs for genetic immunisation |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP0941064B1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 01/11/2006 | EP0831912B1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 01/11/2006 | EP0822822A4 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 01/11/2006 | CN1720264A Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups |
| 01/11/2006 | CN1720262A Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 01/11/2006 | CN1720258A Tumor targeting agents and uses thereof |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 01/11/2006 | CN1720065A Dispersible pharmaceutical compositions |
| 01/11/2006 | CN1720064A Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 01/11/2006 | CN1720057A Chinese patent medicine for treating baldness and preparing process thereof |
| 01/11/2006 | CN1720041A Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 01/11/2006 | CN1720036A Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1720033A Water-soluble composition containing coenzyme q10 |
| 01/11/2006 | CN1720031A Propofol-containing fat emulsions |
| 01/11/2006 | CN1720028A Transdermal analgesic systems with reduced abuse potential |
| 01/11/2006 | CN1720027A Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 01/11/2006 | CN1718616A Medical intelligent nano-gel material and its preparation method |
| 01/11/2006 | CN1718592A Fluorescence labeling hydrophobic modified chitin polymer, its preparation method and application |
| 01/11/2006 | CN1718244A Activated carbon external application antiphlogistine, and its prepn. method |
| 01/11/2006 | CN1718233A Capsule for treating diabetes, and its prepn. process |
| 01/11/2006 | CN1235939C Target hydrophili polymer and its combined object with interferon and medicinal composition containing said combined object |
| 01/11/2006 | CN1235916C Compound comprising crosslinked polyrotaxane |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235641C Medicinal aerosol formulation, its preparing process, use and inhaler containing same |
| 01/11/2006 | CN1235640C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 01/11/2006 | CN1235638C Activated protein C formulations |
| 01/11/2006 | CN1235572C Adhesive preparations |
| 01/11/2006 | CN1235571C Chitosan and fibroin mixed microsphere, its usage and preparing process |
| 01/11/2006 | CN1235570C Microball preparation for intestine orient releasing medicine and its preparing method |
| 01/11/2006 | CN1235568C Aqueous-based pharmaceutical composition |
| 01/11/2006 | CN1235567C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 01/11/2006 | CN1235566C Drondearone pharmaceutical composition for external gastrointestinal-tract administration |
| 01/10/2006 | US6984691 W/O/W composite emulsion |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | US6984632 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
| 01/10/2006 | US6984508 Biological compositions and methods for treatment of cervical cancer |
| 01/10/2006 | US6984507 Biological compositions and methods for treatment of lung cancer |
| 01/10/2006 | US6984403 Azithromycin dosage forms with reduced side effects |
| 01/10/2006 | US6984402 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | US6984395 Drug delivery system for hydrophobic drugs |
| 01/10/2006 | US6984394 Plastically deformable implant |
| 01/10/2006 | US6984393 Combining a star co-polymer with a bis-lactone crosslinking agent, and heating the combined star co-polymer and crosslinking agent, so that a crosslinked biodegradable/biocompatible elastomeric polymer is obtained |
| 01/10/2006 | US6984386 Nanoparticle covering with non-plant virion coat protein shell; prepare by incubation, adjusting PH, control opening an entry on virion to confine, trap the mineral inside; magnetic resonance imaging, contrasting agents, drug delivery |